Changes in the bacteria found in the mouth and gut of Parkinson’s disease patients could act as an early warning sign that their symptoms are worsening, new research suggests. Scientists, using ...

A test that can detect Parkinson's disease in the early stages of the illness has moved a step closer. Scientists have developed a way of detecting a molecule linked to the condition in samples of ...

Your T cells work hard to fight disease. Unfortunately, "friendly fire" from T cells can sometimes harm the body's healthy tissues. For people with autoimmune disease, T cell reactivity is a big ...

Data from Phase IIb PADOVA study and longer term follow-up data suggest clinical benefit on top of symptomatic treatment in early-stage Parkinson’s disease Prasinezumab is a potential first-in-class ...

Prof. Chris Goetz, co-creator of the MDS-UPDRS, is a leading expert in movement disorder pharmacology and rating-scale development. He is a professor in the Department of Neurological Sciences and ...

Study demonstrates a correlation between peripheral pro-inflammatory mechanisms, particularly monocytes and oxidative stress, in the progression and severity of Parkinson’s Disease (PD); In addition ...

Roche RHHBY announced that it will advance pipeline candidate prasinezumab into phase III development for early-stage Parkinson’s disease. Roche has a licensing agreement with Prothena PRTA for ...